 | Up a level |
2018
Meder, L., Koenig, K., Dietlein, F., Florin, A., Koker, M., Buettner, R., Heukamp, L. and Ullrich, R. (2018). LIN28B enhanced tumorigenesis in an autochthonous KRASG12V driven lung carcinoma mouse model. Oncol. Res. Treat., 41. S. 291 - 292. BASEL: KARGER. ISSN 2296-5262
2016
Meder, L., Schuldt, P., Vlasic, I, Volz, C., Golfmann, K., Zaplatina, A., Florin, A., Tharun, L., Buettner, R., Reinhardt, C. and Ullrich, R. (2016). Combining anti-VEGF therapy and immune checkpoint inhibitors improves outcome in small cell lung carcinomas. Oncol. Res. Treat., 39. S. 87 - 88. BASEL: KARGER. ISSN 2296-5262
Volz, C., Zaplatina, A., Siobal, M., Chatterjee, S., Schoettle, J., Meder, L., Florin, A., Koker, M., Buettner, R., Miao, H., Wang, B., Hallek, M., Acker-Palmer, A. S., Heukamp, L. C., Thomas, R. K. and Ullrich, R. (2016). Anti angiogenic treatment induces tumor cell invasion and metastasis via EphA2 signaling in NSCLC. Oncol. Res. Treat., 39. S. 88 - 89. BASEL: KARGER. ISSN 2296-5262
2015
Rabenhorst, A., Leja, S., Florin, A., Foerster, A., Heukamp, L. C., Ullrich, R. T., Willenborg, S., Eming, S., Buettner, R. and Hartmann, K. (2015). Mast cell-derived vascular endothelial growth factor contributes to tumor growth. J. Invest. Dermatol., 135. S. S19 - 1. NEW YORK: NATURE PUBLISHING GROUP. ISSN 1523-1747
Rabenhorst, A., Leja, S., Florin, A., Heukamp, L. C., Ullrich, R. T., Foerster, A., Roers, A., Buettner, R. and Hartmann, K. (2015). Contribution of mast cell-derived VEGF to tumor growth. Exp. Dermatol., 24 (3). S. E33 - 1. HOBOKEN: WILEY-BLACKWELL. ISSN 1600-0625
Rabenhorst, A., Leja, S., Florin, A., Heukamp, L. C., Ullrich, R. T., Foerster, A., Roers, A., Buettner, R. and Hartmann, K. (2015). Contribution of mast cell-derived VEGF to tumor growth. Exp. Dermatol., 24 (3). S. E33 - 1. HOBOKEN: WILEY-BLACKWELL. ISSN 1600-0625